Q32 Bio Inc.
QTTB
$5.94
$0.132.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 33.24M | 29.82M | -42.10M | -52.30M | -59.79M |
| Total Depreciation and Amortization | 362.00K | 391.00K | 421.00K | 453.00K | 483.00K |
| Total Amortization of Deferred Charges | 165.00K | 180.00K | 192.00K | 196.00K | 213.00K |
| Total Other Non-Cash Items | -58.79M | -59.90M | 5.57M | 5.41M | 4.74M |
| Change in Net Operating Assets | -2.38M | -4.04M | -2.87M | -7.84M | -11.29M |
| Cash from Operations | -27.40M | -33.54M | -38.79M | -54.08M | -65.65M |
| Capital Expenditure | -- | -- | -2.00K | -60.00K | -75.00K |
| Sale of Property, Plant, and Equipment | 7.00M | 7.00M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 10.00M | 19.90M |
| Cash from Investing | 7.00M | 7.00M | -2.00K | 9.94M | 19.83M |
| Total Debt Issued | -- | -- | 0.00 | -53.16M | 0.00 |
| Total Debt Repaid | -4.69M | -3.13M | -1.56M | 8.71M | 0.00 |
| Issuance of Common Stock | 10.36M | -- | 317.00K | 1.31M | 1.69M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 44.44M | -5.90M |
| Cash from Financing | 5.67M | -3.13M | -1.25M | 1.31M | -4.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.73M | -29.67M | -40.04M | -42.83M | -50.03M |